...reatly improved with Volk's exclusive Double Asphe... precise and focused laser beam placement at the c...ng and laser treatment of the posterior capsule. T...indow for optimal laser beam transmission and imag...
...offers extremely high resolution treatment capabil...exceptionally wide 78° field of view. This len...f the optic nerve head and macula. Excellent stere...edesigned to reduce weight and size. High magnific...
...ent for critically evaluating and treating subreti...generation, retinal vascular occlusions, diabetic ...and other retinal conditions. It is ideal for foca...cellent magnification combined with a good field o...
...ns has grown in popularity since its introduction ...ens. Its sleek 28.6mm diameter housing provides a ...ses for peripheral retinal viewing, reflection dis... for small pupil fundus examination and as a gener...
Medicine Products:(Date:10/6/2008)...t. 6 /PRNewswire/ -- Developed in collaboration wi...ades, CA is introducing,Revolutionary Breast Surfa...c Surgery office of Dr. Steve Laverson this week i...he first of its kind, and is based on,breakthrough...with,innovative proprietary software. The XS-300(T...
(Date:10/6/2008)...ct. 6 /PRNewswire/ -- The organizers of Informex a...e on Global Sourcing for the,Pharmaceutical Indust...inceton Marriott in New Jersey USA., The conferen... the,Global Sourcing Council, and boasts an unpara...e likes of Johnson & Johnson, Bristol Myers Squibb...
(Date:10/6/2008)... LegalView recently posted detailed inform...he potentially serious side effects caused by the ... the drug,s potential side effects are the develop... for young adult and child patients. , ...- LegalView, the number one resource for everythin...
(Date:10/6/2008)... Hospital Ship Serving in West Africa Rece...Garden Valley, Texas October 6, 2008 -- www.seamob...l provider of communications services to remote lo...s to the FoxNews channel via satellite to Mercy Sh...ica Mercy. The Africa Mercy is the world,s larges...
Breaking Medicine News(10 mins):Health News:Plan Your Breasts in 3-D 2Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3...he problem of increasing risk to bone fractures ma... September issue of Archives of Internal Medicine.... profound impact on quality of life // , with only...re-fracture level of function and a substantial ri...
...ore than 20 million children across 60 districts i...ncephalitis, will be vaccinated against the mosqui...// An outbreak of the disease in the impoverished ...650 people, mostly children, and more than 3,000 i...
...esearchers from National Cancer Institute has test...mbining cancer vaccines and Anti-androgen hormone ...sistance to hormone therapy // but had no metastat...2 Prostate cancer patients with no metastatic spre...
...are eye disorder from genetic sources can also be ...al cardiovascular development. Researchers at Chi...g the genetics // of rare eye-movement disorders,...e implications go far beyond the eye, raising intr...
Other Medicine News:Health News:Combination Therapy To Avoid Prostate Cancer Recurrence 2Health News:Genetic Eye Disorder Can Have Other Implications 2(Date:10/6/2008)...LE, Oct. 6 /- Dendreon Corp... today, Monday, October 6, 2008 at 9:00 AM,ET (6:0...ysis of its IMPACT,(IMmunotherapy for Prostate Ade...cal trial of PROVENGE(R) (sipuleucel-T), the Compa... for the treatment of advanced prostate,cancer., ...
(Date:10/3/2008)...ngton County, New Jersey is the newest study site,...The Children,s Hospital,of Philadelphia today rece...National Children,s Study. Children,s Hospital wil... collection in Burlington County, New,Jersey. The ...th., Investigators anticipate approximately 1,000...
(Date:10/2/2008)...to support Urgent PC clinical success and expanded...rage, MINNEAPOLIS, Oct. 2 /PRNewswire-FirstCall/ ... enrollment of the first patients in a new,randomi...FDA cleared Urgent,PC neuromodulation system for t...of urinary urgency, urge incontinence and frequenc...
(Date:10/2/2008)...ORG, Sweden, October 2 /- Calabar AB ...study in xerostomia ("dry mouth"),patients has bee...d in 45,dry mouth patients between the ages of 20 ...ose for evaluation in a succeeding Phase III effic...holinesterase inhibitor,physostigmine. It is admin...
Breaking Medicine Technology:Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 2Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 3Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 4Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients 2Capella University Launches Online PhD Specialization in Nursing Education 24214 1Capella University Launches Online PhD Specialization in Nursing Education 24214 2Capella University Launches Online PhD Specialization in Nursing Education 24214 3Heart Blood Vessels Grown in the Lab 24212 1Heart Blood Vessels Grown in the Lab 24212 2Suckling Infant Triggers Trust Hormone in Moms 24210 1Suckling Infant Triggers Trust Hormone in Moms 24210 2Breast Fed Babies Have Fewer GI Infections 24208 1Breast Fed Babies Have Fewer GI Infections 24208 2...stCall/ -- Baxter,International Inc. today announc...estigational pandemic H5N1 influenza vaccine and,p... candidate,vaccine in Europe to confirm the study ...ter,s H5N1 candidate,vaccine is highly immunogenic...ross immunity against widely divergent H5N1 strain...
...tola,Pharmaceuticals, Inc. presented Phase I data ...y,s (ACC) 56th Annual Scientific,Session this week...60128, appeared safe and well-tolerated in this st... Portola presented the data in a poster session ti...New Direct-acting, Reversible,P2Y(12) Inhibitor fo...
Other Medicine Technology:Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5Portola Pharmaceuticals Presents Positive Phase I Data of Its ADP,Receptor Antagonist at the American College of Cardiology 2